Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1642

1.

Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.

Holzgreve H, Nakov R, Beck K, Janka HU.

Am J Hypertens. 2003 May;16(5 Pt 1):381-6.

PMID:
12745200
[PubMed - indexed for MEDLINE]
2.

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators.

JAMA. 2003 Dec 3;290(21):2805-16.

PMID:
14657064
[PubMed - indexed for MEDLINE]
3.

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

Ruilope LM, Usan L, Segura J, Bakris GL.

J Hypertens. 2004 Jan;22(1):217-22.

PMID:
15106814
[PubMed - indexed for MEDLINE]
4.

Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.

Muijsers RB, Curran MP, Perry CM.

Drugs. 2002;62(17):2539-67. Review.

PMID:
12421112
[PubMed - indexed for MEDLINE]
5.

Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.

Schneider M, Lerch M, Papiri M, Buechel P, Boehlen L, Shaw S, Risen W, Weidmann P.

J Hypertens. 1996 May;14(5):669-77.

PMID:
8762212
[PubMed - indexed for MEDLINE]
6.

Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.

Bakris GL, Cooper-Dehoff RM, Zhou Q, Kupfer S, Champion A, Pepine CJ; INVEST Investigators.

Am J Cardiovasc Drugs. 2007;7 Suppl 1:25-9.

PMID:
19845074
[PubMed - indexed for MEDLINE]
7.

Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.

García de Vinuesa S, Luño J, Gómez-Campderá F, Ridao N, Sánchez M, Dall'Anese C, Valderrábano F.

Nephrol Dial Transplant. 2001;16 Suppl 1:78-81.

PMID:
11369828
[PubMed - indexed for MEDLINE]
8.

Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.

Messerli F, Frishman WH, Elliott WJ.

Am J Hypertens. 1998 Mar;11(3 Pt 1):322-7.

PMID:
9544873
[PubMed - indexed for MEDLINE]
9.
10.

The fixed combination of verapamil SR/trandolapril.

Widimský J.

Expert Opin Pharmacother. 2000 Mar;1(3):515-35. Review.

PMID:
11249535
[PubMed - indexed for MEDLINE]
11.

Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.

DeQuattro V, Lee D, Messerli F.

Clin Exp Hypertens. 1997 Apr;19(3):373-87.

PMID:
9107443
[PubMed - indexed for MEDLINE]
12.

Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.

de Leeuw PW, Notter T, Zilles P.

J Hypertens. 1997 Jan;15(1):87-91.

PMID:
9050975
[PubMed - indexed for MEDLINE]
13.

Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.

DeQuattro V, Lee D.

Am J Hypertens. 1997 Jul;10(7 Pt 2):138S-145S.

PMID:
9231890
[PubMed - indexed for MEDLINE]
14.

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Circulation. 2006 May 9;113(18):2201-10. Epub 2006 May 1.

PMID:
16651474
[PubMed - indexed for MEDLINE]
Free Article
15.

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.

Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ; INVEST Investigators.

Am Heart J. 2008 Aug;156(2):241-7. doi: 10.1016/j.ahj.2008.02.023.

PMID:
18657652
[PubMed - indexed for MEDLINE]
16.

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group.

JAMA. 2003 Apr 23-30;289(16):2073-82.

PMID:
12709465
[PubMed - indexed for MEDLINE]
17.

Fixed combination verapamil SR/trandolapril.

Dooley M, Goa KL.

Drugs. 1998 Nov;56(5):837-44; discussion 845-6. Review.

PMID:
9829157
[PubMed - indexed for MEDLINE]
19.

Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group.

Holzgreve H, Compagnone D, Zilles P.

J Hum Hypertens. 1999 Jan;13(1):61-7.

PMID:
9928754
[PubMed - indexed for MEDLINE]
20.

Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.

Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG.

Int J Clin Pharmacol Ther. 1998 Aug;36(8):425-31.

PMID:
9726695
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk